Realizations in Biostatistics

Biostatistics, clinical trial design, critical thinking about drugs and healthcare, skepticism, the scientific process.

Monday, May 11, 2009

I'm all for studying comparative effectiveness, but ...

Eye on FDA explains very well my concerns with comparative effectiveness research.

Posted by Unknown at 7:01 AM

Labels: comparative effectiveness

Newer Post Older Post Home

About Me

Unknown

View my complete profile

Share

Subscribe

Posts

Posts

Comments

Comments

Twitter Updates

Twitter Updates

follow me on Twitter

Popular Posts

Followon to polling post

Seems like the guy at fivethirtyeight.com is pretty on top of polling methods, including modeling of the polling data (weighting by past pe...
O'Brien-Fleming designs in practice

It seems that the O'Brien-Fleming design is the most popular of all group sequential clinical trial designs. This particular strategy re...
Matrix square roots in R

There are a couple of ways to do matrix square roots in R. The first is through eigendecomposition: # a is the matrix for which we want ...
Windows 10 anniversary updates includes a whole Linux layer - this is good news for data scientists

If you are on Windows 10, no doubt you have heard that Microsoft included the bash shell in its 2016 Windows 10 anniversary update. What you...
I set up a new data analysis blog

Well, I tried to write a blog post using the RStudio Rmarkdown system, and utterly failed. Thus, I set up a system where I could write from...

Recent drug development and statistics content

Eye on FDA

FDA Adds New AdComm to Address Genetic Metabolic Diseases - Back in December 2023, FDA announced intention in the Federal Register and in a press release to form a new FDA Advisory Committee to be called the Genetic...
1 month ago
Junk Charts

Losing the plot while stacking up the bars - Kaiser looks at an infographic about dirty American cities.
7 months ago
FDA Law Blog

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care - By McKenzie E. Cato —
2 years ago
FDA newsfeed

FDA approves device to help increase access to more lungs for transplant - The device enables doctors to better assess lungs that were initially deemed to be unsuitable for transplant
4 years ago
WSJ.com: Health Blog

Is a Paleo Diet Healthier Than Standard Nutritional Guidelines? - Is the paleo diet better for you than standard nutritional guidelines? Take our survey and let us know.
9 years ago
Statistical Modeling, Causal Inference, and Social Science

-
Pharmalot

-
In the Pipeline

-

Personal Links

My family blog
My other opinions

Statistics and Data Analysis

Stats blogs
R-bloggers
The Do Loop
The SAS dummy
Revolution Analytics
Effective Graphs
Statistics Forum
Chance News at Dartmouth
Epidemiology Methods Blog
Flowing Data
Gapminder
Introduction to Bayesian Thinking
John Cook
Junk Charts
Lies and Stats
Mathematical Epidemiology
Radford Neal
Statistical Modeling, Causal Inference, and Social Science
UN Statistics Division Common Database

R

R bloggers

Navigating R’s Impact in Vienna: Insights from the Finance and Pharmaceutical Sectors
18 hours ago
SAS and R

Project MOSAIC migrates to ggformula
5 years ago
R-Chart

Investigating Cryptocurrencies (Part II)
6 years ago
Cerebral Mastication

Teens and the Internet…
9 years ago
One R Tip A Day

Summer Reading
10 years ago
Learning R

Consultants’ Chart in ggplot2
13 years ago
Programming R - Articles
Revolutions

Drug development

Pharma IQ
FDA home page
FDA Critical Path
Clinical Trials Today
PhRMA
Ask Cato
Cato Research

Clinical trials

On biostatistics and clinical trials
Good Clinical Trial Simulation Practices
PhRMA's clinical study results
Government's registry of clinical trials

Labels

adaptive trials (11) alternative medicine (2) alzheimer's disease (2) analysis (1) analytics (2) ANOVA (1) antibiotics (1) Ask Cato (1) autism (1) Avandia (2) Bayesian statistics (15) bias (2) big data (2) biomarkers (1) biostatistics (12) blinding (4) blogging (10) Blogkeeping (2) books (2) Brexit (1) careers (3) causal inference (3) central nervous system (1) CETP inhibitors (1) chaos (1) classes (3) clinical trials (39) comparative effectiveness (2) compliance (1) consulting (3) contests (1) correlation (1) coursera (2) crf (1) critical path initiative (1) critical thinking (5) data cleaning (1) data collection (3) data mining (5) data science (1) databases (1) delta method (1) drug development (2) drugs (2) echinacaea (1) Ed Silverman (1) education (5) eli lilly (1) email (1) EMEA (1) ENHANCE (2) epidemiology (3) FDA (6) free (1) Google (1) graduate school (1) graphics (6) group sequential (4) Hal Varian (1) humor (1) Inference for R (2) intention to treat (1) interpretation (4) John Tukey (1) joint statistical meetings (2) JSM (2) JUPITER (1) Lan-DeMets (1) leadership (4) learning (2) learning from data (1) links (1) Little Debate (2) loess (2) lying with statistics (13) machine learning (4) Mantel-Haenszel (1) marketing (1) mathematics (2) matrix (2) MedDRA (1) metaanalysis (1) Microsoft (1) Microsoft Excel (1) Microsoft Word (2) missing data (1) modeling (2) modern regression (1) mooc (4) multiple comparisons (1) multiple sclerosis (1) natural language processing (2) networking (1) neurology (1) NNT (3) noninferiority (2) o'brien-fleming (1) observational (2) odds (1) open data (1) Other blogs (7) p-values (3) PD (1) Peter Rost (2) pharmaceutical industry (3) pharmacogenomics (2) Pharmalot (2) Phase 2 (1) phase 3 (3) Phase I (1) PK (1) politics (7) polls (4) postmarketing (1) practice of statistics (3) Presentations (2) privacy (1) probability (1) professionalism (3) proof (1) publishing (1) Python (2) R (26) random number generation (1) randomization (3) relationships (2) risk (1) RStudio (1) RTF (2) safety (7) SAS (8) SAS programmer (1) science (1) simple statistics (1) simulation (2) skepticism (4) smoothing (1) social media (1) social network analysis (4) software (1) statins (1) statistical analysis plan (1) statistical leadership (1) statistical programming (8) statistical significance (3) statistics (31) statistics forum (2) statistics without borders (1) surveys (1) t test (1) tables (1) Taylor series (1) TGN1412 (2) torcetrapib (1) twitter (1) Type I error (2) Ultraedit (2) vaccination (3) visualization (2) waste (4) Windows (1) writing (1)

Blog Archive

► 2016 (6)
- ► December (1)
- ► September (1)
- ► June (2)
- ► May (1)
- ► January (1)

► 2015 (8)
- ► November (1)
- ► October (2)
- ► May (1)
- ► April (2)
- ► March (2)

► 2014 (2)
- ► December (2)

► 2013 (12)
- ► August (1)
- ► July (1)
- ► April (2)
- ► March (4)
- ► February (4)

► 2012 (28)
- ► December (1)
- ► November (5)
- ► October (4)
- ► September (2)
- ► August (8)
- ► May (2)
- ► April (2)
- ► March (2)
- ► January (2)

► 2011 (26)
- ► December (7)
- ► October (1)
- ► September (3)
- ► August (2)
- ► June (2)
- ► May (1)
- ► March (1)
- ► February (1)
- ► January (8)

► 2010 (50)
- ► December (3)
- ► November (2)
- ► October (3)
- ► September (8)
- ► August (8)
- ► July (5)
- ► June (5)
- ► May (4)
- ► April (4)
- ► March (5)
- ► February (3)

▼ 2009 (28)
- ► December (1)
- ► November (2)
- ► October (1)
- ► September (1)
- ► August (1)
- ► July (3)
- ► June (5)
- ▼ May (6)
- ► April (2)
- ► March (3)
- ► January (3)

► 2008 (47)
- ► December (2)
- ► November (4)
- ► October (5)
- ► September (7)
- ► August (5)
- ► July (4)
- ► June (3)
- ► May (7)
- ► April (2)
- ► February (2)
- ► January (6)

► 2007 (32)
- ► December (1)
- ► November (3)
- ► September (3)
- ► August (9)
- ► July (2)
- ► June (2)
- ► May (2)
- ► April (3)
- ► March (2)
- ► February (3)
- ► January (2)

► 2006 (3)
- ► December (3)

Site Meter

Awesome Inc. theme. Powered by Blogger.